Mesirow Institutional Investment Management »

Halozyme Therapeutics shares owned by Mesirow Institutional Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mesirow Institutional Investment Management from 13F filings

Historical chart of Mesirow Institutional Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mesirow Institutional Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mesirow Institutional Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 454k 36.96
2023-09-30 $15M 380k 38.20
2023-06-30 $15M 423k 36.07
2023-03-31 $13M 333k 38.19